• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.心脏病。诱导多能干细胞中的肌联蛋白突变将肌节功能不全定义为扩张型心肌病的一个病因。
Science. 2015 Aug 28;349(6251):982-6. doi: 10.1126/science.aaa5458.
2
Reading Frame Repair of Truncation Variants Restores Titin Quantity and Functions.阅读框修复截断变异体可恢复肌联蛋白的数量和功能。
Circulation. 2022 Jan 18;145(3):194-205. doi: 10.1161/CIRCULATIONAHA.120.049997. Epub 2021 Dec 14.
3
Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy.肌联蛋白突变型扩张型心肌病诱导多能干细胞衍生心肌细胞的功能异常。
PLoS One. 2018 Oct 17;13(10):e0205719. doi: 10.1371/journal.pone.0205719. eCollection 2018.
4
Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function.Cronos 肌联蛋白在人心肌细胞中表达,对于正常的肌节功能是必需的。
Circulation. 2019 Nov 12;140(20):1647-1660. doi: 10.1161/CIRCULATIONAHA.119.039521. Epub 2019 Oct 7.
5
Bringing It All Together: Bedside to Bench and Back Again.融会贯通:从床边到实验室,再回归临床
Circ Res. 2015 Dec 4;117(12):987-9. doi: 10.1161/CIRCRESAHA.115.307874.
6
Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.与扩张型心肌病相关的肌联蛋白截断突变改变了其依赖长度的激活及其通过磷酸化的调节。
Cardiovasc Res. 2022 Jan 7;118(1):241-253. doi: 10.1093/cvr/cvaa316.
7
Force Generation via β-Cardiac Myosin, Titin, and α-Actinin Drives Cardiac Sarcomere Assembly from Cell-Matrix Adhesions.通过β-心脏肌球蛋白、肌联蛋白和α-辅肌动蛋白产生的力驱动细胞-基质黏附处的心肌肌节组装。
Dev Cell. 2018 Jan 8;44(1):87-96.e5. doi: 10.1016/j.devcel.2017.12.012.
8
Titin-truncating variants in hiPSC cardiomyocytes induce pathogenic proteinopathy and sarcomere defects with preserved core contractile machinery.在 hiPSC 心肌细胞中截断的 titin 变体诱导致病蛋白病变和有保留核心收缩机制的肌节缺陷。
Stem Cell Reports. 2023 Jan 10;18(1):220-236. doi: 10.1016/j.stemcr.2022.11.008. Epub 2022 Dec 15.
9
Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy.反义介导的外显子跳跃:一种针对基于肌联蛋白的扩张型心肌病的治疗策略。
EMBO Mol Med. 2015 May;7(5):562-76. doi: 10.15252/emmm.201505047.
10
A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.RNA 结合蛋白 20 的谷氨酸丰富区的突变通过肌联蛋白的错剪接和弗兰克-斯塔尔机制受损导致扩张型心肌病。
Cardiovasc Res. 2016 Oct;112(1):452-63. doi: 10.1093/cvr/cvw192. Epub 2016 Aug 5.

引用本文的文献

1
Cardiac Development, Cellular Composition and Function: From Regulatory Mechanisms to Applications.心脏发育、细胞组成与功能:从调控机制到应用
Cells. 2025 Sep 5;14(17):1390. doi: 10.3390/cells14171390.
2
Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease.在人类心房疾病模型中,TBX5剂量减少会破坏心房心肌细胞特性的发育控制。
bioRxiv. 2025 Aug 19:2025.08.16.669546. doi: 10.1101/2025.08.16.669546.
3
The important regulatory role of glucose concentration in the maturation of stem cell-derived cardiomyocytes: A review.葡萄糖浓度在干细胞衍生心肌细胞成熟中的重要调节作用:综述
Medicine (Baltimore). 2025 Aug 15;104(33):e43878. doi: 10.1097/MD.0000000000043878.
4
Cardiac magnetic resonance markers of pre-clinical hypertrophic and dilated cardiomyopathy in genetic variant carriers.基因变异携带者临床前期肥厚型和扩张型心肌病的心脏磁共振标志物
BMC Med. 2025 Jul 15;23(1):421. doi: 10.1186/s12916-025-04226-4.
5
Deregulated nutrient response in ttntv cardiomyopathy can be repaired via Erk inhibition for cardioprotective effects.通过抑制Erk修复TTNTv心肌病中失调的营养反应可产生心脏保护作用。
J Mol Cell Cardiol. 2025 Jul 11;206:27-38. doi: 10.1016/j.yjmcc.2025.07.006.
6
Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy.诱导多能干细胞在心肌病中的应用:推动疾病建模、治疗开发和再生治疗
Int J Mol Sci. 2025 May 22;26(11):4984. doi: 10.3390/ijms26114984.
7
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
8
Identification of the clinical value and biological effects of TTN mutation in liver cancer.肝癌中TTN突变的临床价值及生物学效应的鉴定
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13530. Epub 2025 Apr 17.
9
Advances in human induced pluripotent stem cell (hiPSC)-based disease modelling in cardiogenetics.基于人类诱导多能干细胞(hiPSC)的心脏遗传学疾病建模研究进展。
Med Genet. 2025 Apr 8;37(2):137-146. doi: 10.1515/medgen-2025-2009. eCollection 2025 Jun.
10
Antisense-mediated regulation of exon usage in the elastic spring region of Titin modulates sarcomere function.反义介导的肌联蛋白弹性弹簧区域外显子使用调控调节肌节功能。
Cardiovasc Res. 2025 May 6;121(4):629-642. doi: 10.1093/cvr/cvaf037.

本文引用的文献

1
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.健康与疾病状态下肌联蛋白截短对心脏影响的等位基因、转录组及表型组综合剖析
Sci Transl Med. 2015 Jan 14;7(270):270ra6. doi: 10.1126/scitranslmed.3010134.
2
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.功能性多能干细胞衍生的心脏微组织的设计和配方。
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4698-707. doi: 10.1073/pnas.1311120110. Epub 2013 Nov 19.
3
Dilated cardiomyopathy: the complexity of a diverse genetic architecture.扩张型心肌病:多样化遗传结构的复杂性。
Nat Rev Cardiol. 2013 Sep;10(9):531-47. doi: 10.1038/nrcardio.2013.105. Epub 2013 Jul 30.
4
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.用于人胚胎干细胞来源的心肌细胞的高级功能成熟的组织工程心脏贴片。
Biomaterials. 2013 Jul;34(23):5813-20. doi: 10.1016/j.biomaterials.2013.04.026. Epub 2013 May 2.
5
RNA-guided human genome engineering via Cas9.通过 Cas9 进行 RNA 引导的人类基因组工程。
Science. 2013 Feb 15;339(6121):823-6. doi: 10.1126/science.1232033. Epub 2013 Jan 3.
6
Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.在完全定义的条件下,通过调节 Wnt/β-catenin 信号转导从人多能干细胞定向分化心肌细胞。
Nat Protoc. 2013 Jan;8(1):162-75. doi: 10.1038/nprot.2012.150. Epub 2012 Dec 20.
7
Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes.独特的代谢流可实现大规模纯化鼠和人多能干细胞来源的心肌细胞。
Cell Stem Cell. 2013 Jan 3;12(1):127-37. doi: 10.1016/j.stem.2012.09.013. Epub 2012 Nov 15.
8
MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.用于心血管疾病的 microRNA 治疗学:机遇与障碍。
Nat Rev Drug Discov. 2012 Nov;11(11):860-72. doi: 10.1038/nrd3864. Epub 2012 Oct 19.
9
microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling.microRNA-124 通过靶向 STAT3 信号通路调节骨髓间充质干细胞向心肌细胞的分化。
Stem Cells. 2012 Aug;30(8):1746-55. doi: 10.1002/stem.1154.
10
MicroRNA 16 enhances differentiation of human bone marrow mesenchymal stem cells in a cardiac niche toward myogenic phenotypes in vitro.微小 RNA 16 增强体外人心骨髓间充质干细胞在心脏龛中的向肌性表型的分化。
Life Sci. 2012 Jun 27;90(25-26):1020-6. doi: 10.1016/j.lfs.2012.05.011. Epub 2012 Jun 4.

心脏病。诱导多能干细胞中的肌联蛋白突变将肌节功能不全定义为扩张型心肌病的一个病因。

HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.

作者信息

Hinson John T, Chopra Anant, Nafissi Navid, Polacheck William J, Benson Craig C, Swist Sandra, Gorham Joshua, Yang Luhan, Schafer Sebastian, Sheng Calvin C, Haghighi Alireza, Homsy Jason, Hubner Norbert, Church George, Cook Stuart A, Linke Wolfgang A, Chen Christopher S, Seidman J G, Seidman Christine E

机构信息

Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.

Department of Biomedical Engineering, Boston University, Boston, MA 02215, USA. The Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA 02115, USA.

出版信息

Science. 2015 Aug 28;349(6251):982-6. doi: 10.1126/science.aaa5458.

DOI:10.1126/science.aaa5458
PMID:26315439
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC4618316/
Abstract

Human mutations that truncate the massive sarcomere protein titin [TTN-truncating variants (TTNtvs)] are the most common genetic cause for dilated cardiomyopathy (DCM), a major cause of heart failure and premature death. Here we show that cardiac microtissues engineered from human induced pluripotent stem (iPS) cells are a powerful system for evaluating the pathogenicity of titin gene variants. We found that certain missense mutations, like TTNtvs, diminish contractile performance and are pathogenic. By combining functional analyses with RNA sequencing, we explain why truncations in the A-band domain of TTN cause DCM, whereas truncations in the I band are better tolerated. Finally, we demonstrate that mutant titin protein in iPS cell-derived cardiomyocytes results in sarcomere insufficiency, impaired responses to mechanical and β-adrenergic stress, and attenuated growth factor and cell signaling activation. Our findings indicate that titin mutations cause DCM by disrupting critical linkages between sarcomerogenesis and adaptive remodeling.

摘要

截断巨大的肌节蛋白肌联蛋白的人类突变[肌联蛋白截断变体(TTNtvs)]是扩张型心肌病(DCM)最常见的遗传病因,DCM是心力衰竭和过早死亡的主要原因。在此我们表明,由人类诱导多能干细胞(iPS)构建的心脏微组织是评估肌联蛋白基因变体致病性的强大系统。我们发现某些错义突变,如TTNtvs,会降低收缩性能并具有致病性。通过将功能分析与RNA测序相结合,我们解释了为什么肌联蛋白A带结构域的截断会导致DCM,而I带的截断则更易耐受。最后,我们证明iPS细胞衍生的心肌细胞中的突变型肌联蛋白会导致肌节功能不全、对机械和β-肾上腺素能应激的反应受损,以及生长因子和细胞信号激活减弱。我们的研究结果表明,肌联蛋白突变通过破坏肌节生成与适应性重塑之间的关键联系导致DCM。